Board Meetings for METROPOLIS
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| METROPOLIS | Metropolis Healthcare Limited | 08 Nov 2022 | Financial results | Metropolis Healthcare Limited has informed the Exchange that Meeting of the Board of Directors of the Company is scheduled on Tuesday, November 08, 2022, to inter alia, consider and approve the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2022. | |
| METROPOLIS | Metropolis Healthcare Limited | 10 Aug 2022 | Financial results | Metropolis Healthcare Limited has informed the Exchange about Board Meeting to be held on 10-Aug-2022 to consider unaudited financial results for the quarter ended June 2022 | |
| METROPOLIS | Metropolis Healthcare Limited | 18 Jul 2022 | Other business matters | Metropolis Healthcare Limited has informed the Exchange about Board Meeting to be held on July 18, 2022, to consider and approve revised Audited Standalone Financial results for the quarter and year ended March 31, 2022, after taking on record the amalgamation of the 8 (Eight) wholly- owned subsidiary Companies with the Company. | |
| METROPOLIS | Metropolis Healthcare Limited | 24 May 2022 | Financial results | Metropolis Healthcare Limited has informed the Exchange about Board Meeting to be held on 24-May-2022 to consider financial statements for the period ended March 2022 | |
| METROPOLIS | Metropolis Healthcare Limited | 11 Feb 2022 | Financial Results/Dividend | To consider and approve the financial results for the period ended December 31, 2021 and interim dividend, if any | |
| METROPOLIS | Metropolis Healthcare Limited | 10 Nov 2021 | Financial Results | To consider and approve the financial results for the period ended September 30, 2021 | |
| METROPOLIS | Metropolis Healthcare Limited | 06 Aug 2021 | Financial Results/Fund Raising/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2021, Fund Raising and other business matters | |
| METROPOLIS | Metropolis Healthcare Limited | 27 May 2021 | Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2021 and other business matters | |
| METROPOLIS | Metropolis Healthcare Limited | 10 Feb 2021 | Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended December 31, 2020, dividend and other business matters | |
| METROPOLIS | Metropolis Healthcare Limited | 17 Jan 2021 | Other business matters | Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Sunday January 17, 2021. | |
| METROPOLIS | Metropolis Healthcare Limited | 11 Nov 2020 | Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2020 and other business matters | |
| METROPOLIS | Metropolis Healthcare Limited | 11 Aug 2020 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2020 | |
| METROPOLIS | Metropolis Healthcare Limited | 29 May 2020 | Financial Results/Other business matters | This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, May 29, 2020 to inter-alia consider and approve the Audited Standalone and Consolidated Financial statements of the Company for the quarter and financial year ended March 31, 2020 | |
| METROPOLIS | Metropolis Healthcare Limited | 06 Feb 2020 | Financial Results | To consider and approve the financial results for the period ended December 31, 2019 | |
| METROPOLIS | Metropolis Healthcare Limited | 06 Feb 2020 | Financial Results/Dividend | The Company had informed the Exchange regarding a Board Meeting scheduled to be held on February 06, 2020 To consider and approve the financial results for the period ended December 31, 2019. The Company has now informed the Exchange that the aforesaid also consider the declaration of interim dividend, if any, for the financial year 2019-20.( Purpose Revised) |